Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy

Autor: de Crevoisier, R. *, Slimane, K., Messai, T., Wibault, P., Eschwege, F., Bossi, A., Koscielny, S., Bridier, A., Massard, C., Fizazi, K.
Zdroj: In Annals of Oncology April 2010 21(4):808-814
Databáze: ScienceDirect